|
What
is Male Erectile Dysfunction or Impotence?
Male
erectile dysfunction or impotence is the inability
for a sexually active male to obtain and sustain
an erection for sexual purposes. This in the past
has been a very embarrassing subject for many
men and their partners, and, in fact, there has
been very little diagnostic testing or treatments
available up until 1973.
This problem affects at least 30 percent of all
adult males and 50 percent of all males over 40
years of age. Some 85 percent of the causes for
MED are physical and are organic and due to an
actual physical problem, disease entity, or complication
of another illness. In general, 40 percent of
all 40-year-olds, 50 percent of all 50-year-olds,
and 60percent of all 60-year-olds have some form
of MED although in general only 15 percent are
of the severe form, that is to say inability to
totally obtain any erections whatsoever.
With
the advent of an effective oral and safe medication
Viagra (Sildenafil) the entire evaluation and
treatments for male erectile dysfunction have
become revolutionized. Other forms of therapy
including self injection programs with vasoactive
drugs, intraurethral placement of vasoactive drugs,
external vacuum compression device, and implantation
of inflatable penile prostheses are still available
and have a place in the armamentarium of the urologist
who deals in the problems of sexual dysfunction
in men.
In
general, with the advent of Viagra in March of
1998 the numbers of patients seen by physicians
have increased two-fold, and in general up to
75 percent of the patients will respond to Viagra.
The remainder will need other treatment modalities,
some of which include combinations with Viagra.
Any physician can prescribe Viagra; however the
specialists who know the most about Viagra are
urologists who specialize in the field of male
sexual dysfunction. In those cases in which Viagra
does not work, where the results are suboptimal,
or in situations in which the cause for the impotence
is not obvious, a patient should be seen by a
specialist.
Diagnosis
and Evaluation:
Of the thirty million American men with chronic
impotence not all need significant and expensive
diagnostic evaluations. Patients with an obvious
cause for their sexual dysfunction or patients over
60 years of age probably need a minimal amount of
diagnostic testing. Most of the tests necessary
are blood tests frequently done by their primary
care or internal medicine physicians. If there is
a sexual desire problem a total testosterone and
a prolactin blood test should definitely be performed
in addition to the routine blood count and chemical
profiles most patients normally have. For this group
of patients a trial of Viagra would be best, and
if response is good without side effects continuation
of the drug should be done.
On
the other hand, in that group of impotent men
who are under 60 years of age and the diagnosis
is not obvious, diagnostic testing should be performed
to determine the etiology of their sexual dysfunction
even if Viagra in the end is an effective form
of therapy. Remember, the sexual dysfunction of
impotence is a symptom of another problem.
Many
times the other problem can be resolved which
will resolve the sexual dysfunction. In addition,
frequently the other problem has medical sequelae
that are more dangerous than the impotence. For
example, one-third of the patients who have undiagnosed
cardiovascular disease and who present with impotence
as the first symptom of their cardiovascular problem
will have some cardiovascular complication such
as a heart attack or stroke within three years
of diagnosing or treatment their sexual dysfunction.
This
group of patients requiring special diagnostic
studies should certainly be seen by their urologic
specialist who will not only do the routine bloods,
CBC and chemistry profile, and the hormone studies,
total testosterone, prolactin, and possibly free
testosterone with LH and FSH levels, but will
seriously consider doing nocturnal penile sleep
studies to determine whether this is a physical
organic problem or a psychogenic problem. The
reason for doing these sophisticated studies is
not just to determine the cause, but also to give
a prognosis as to how long treatment may be necessary,
and lastly to objectively measure the severity
of the problem and assist in determining how much
medicine or treatment will be necessary and what
doses should be started with.
In
rare situations probably representing less than
10 percent of patients who are young, the diagnosis
is organic on the basis of sleep studies (Rigiscan
testing), and where the blood studies are normal
including hormone studies; the urologist specialist
may consider more aggressive vascular testing
procedures including Doppler flow studies of the
penis, angiography, and x-ray pictures of the
penis in the erect state using contrast material
(cavernosometry) along with penile pressure studies
(cavernosometrics).
Special Diagnostic Tests:
Obviously
basic blood studies including blood count, CBC,
chemical profile, and hormone tests including
the male hormones testosterone total and free,
prolactin, and the pituitary luteinizing hormones
(LH) and follicle stimulating hormone (FSH) are
frequently drawn on a routine basis. General illness
can be determined from the red and white blood
counts. Kidney and liver function which can affect
sexual function are determined by certain chemical
evaluations such as the BUN, creatinine, and various
enzyme studies including the bilirubin. Diabetes
can be ruled out or questioned based upon the
blood sugar level, and obviously patients who
have elevated cholesterol and triglycerides run
a greater risk of high blood pressure and hardening
of the arteries.
The
male hormone testosterone should absolutely be
performed in patients who have poor sexual desire
since most impotent men have normal desire with
normal hormone levels. Desire problems are frequently
found only in patients with elevated prolactins
which should also be obtained, low testosterones,
or psychogenic causes for their erectile dysfunction.
Nocturnal
Penile Tumescence (Rigiscan Sleep Studies)
Sleep
studies, in general, should only be performed
in younger males, i.e. less than sixty years of
age in which the etiology of the impotence is
not obvious and all patients, no matter what their
age, if they wish to differentiate psychological
from organic causes for the sexual dysfunction
and possibly the specific etiology of their organic
disease. Sleep studies, in general, are based
upon the principle that all men from birth to
death, have erections every ninety minutes, three
to five times at night lasting fifteen to thirty
minutes of a certain intensity and rigidity.
Patients
with a psychological cause for their impotence
will have a perfectly normal sleep biorhythm,
whereas patients who have a physical cause (organic)
will have some abnormality of the frequency, intensity
or duration of their sleep erections. Other nonquantitative
ways of measuring sleep erections would include
the stamp test in which a roll of stamps are placed
around mid-shaft of the penis with the sticky
side out for two to three nights to see if the
stamps break, i.e., indicating at least one good
erection to break the stamps.
Or,
using a more sophisticated stamp test called the
Snap Gauge manufactured by Dianon Corporation
which not only tells you that there is one good
erection at night, but it also determines the
strength of the erection, i.e., weak, moderate,
or strong. In general, Rigiscan sleep studies
are the best way of determining what the nocturnal
erection sleep cycle is like. Men can have one
good erection at night, but this is, in fact,
not normal, since most men have three to five
erections at night. Snap Gauge and stamp tests
will only demonstrate one erection and cannot
quantitatively demonstrate the other erections
at night.
Cavernosometrics and Cavernosometry
In
very unusual and rare situations, in order to
demonstrate a venous leak problem, doctors may
do cavernosometry and cavernosography. In cavernosometry
saline is infused into the corpora cavernosa after
inducing an erection, usually with Prostaglandin
intracavernosal pharmacotherapy and determining
how many ccs of water it takes to maintain the
erection. If dye is injected into the penis with
a tourniquet around the base of the penis one
can also determine the venous outflow of the penis,
see if the leakage is focal and surgically correctable,
or as in most situations a diffuse leak which
is not correctable.
Most
cases of venous leak problems are really arterial
insufficiency problems and the handling of venous
leak is through the increase of blood flow into
the penis by other therapies including Viagra,
intraurethral Prostaglandin (Muse), and/or intracavernosal
injections of pharmacologically active drugs such
as Prostaglandin E-1 (Caverject).
Pudendal Angiography
Again,
in rare and unusual circumstances in which a relatively
young male, under 55 years of age, who has a history
of pelvic trauma from an automobile accident and/or
motorcycle accident in which the pelvis was fractured,
would pudendal angiography be considered. Before
doing the angiography a Doppler flow study or
digital flow studies of the penis would be done
to see if there was abnormal flow to the various
arteries of the penis. In those circumstances
in which the Doppler flow or digital flow was
abnormally low, and at which there was an appropriate
history of a pelvic fracture in a relatively young
diabetic male, pudendal angiography could be considered,
especially if it was felt that arterial reconstructive
surgery would be helpful in this patient. In general,
arterial reconstructive surgery for impotence
is unsuccessful since most patients are elderly,
already have small vessel vascular disease, or
are diabetic. Doppler flow studies and angiography
would not be done in most of these circumstances.
Treatment Modalities
A. Oral Medications
Oral medications at this time include Viagra (Sildenafil)
a potent type 5 phosphodiesterase inhibitor, yohimbine,
trazodone (Desyrel), and methylated testosterone.
In general, Viagra is the most potent and best
way of handling male erectile dysfunction. It
was introduced on March 27, 1998 and is effective
in approximately 75-80 percent of all men with
erectile dysfunction, 40 percent of all men with
radical prostatectomies, and most men with psychogenic
impotence. Viagra should probably be tried by
all men who have erectile dysfunction no matter
what degree of impotence they have. The only contraindications
include: taking of organic nitrates and nitroglycerin,
Sildenafil hypersensitivity, severe cardiac disease
in which sexual function if prohibited, and the
rare eye disease retinitis pigmentosa. The drug
is taken one to four hours prior to sexual activity
and needs sexual stimulation to be effective.
The side effects include: mild headaches, facial
flushing, stomach upset and unusual ocular disturbances
including a bright vision and a blue-green halo
around the vision.
When
these symptoms occur they are usually of short
duration, lasting less than 15 to 30 minutes and
of mild degree and always self limiting. In the
future there will be newer, more potent and more
specific Viagra-like drugs. All these drugs work
by inhibiting the inhibitor cyclic GMP, therefore
causing an increased production of nitric oxide
by the lining of the blood vessels of the penis.
The nitric oxide acts as a potent poison to the
muscles of the blood vessels, dilating the blood
vessels, increasing blood flow to the penis and
causing penile engorgement.
Yohimbine
such as in the form of Yocon 5.4 mg has been used
in the past and is effective in approximately
25-35 percent of patients with erectile dysfunction.
There is question whether it has a true pharmacologic
effect, and whether or not its major effect is
placebo. Its major side effects are: hypertension,
cardiac arrhythmia, and anxiety production. With
the introduction of Viagra, the question arises
whether yohimbine should or should not be utilized
by urologists who specialize in this field.
Trazodone
or Desyrel is an antidepressant whose side effects
include an erection that will not go away, i.e.
priapism. In depressed impotent men this drug
may have a place although with the advent of Viagra
its use is limited.
Oral
testosterones in the form of methylated testosterone
should probably never be used because of its major
and serious side effect cholestatic jaundice and
hepatic toxicity. If patients are found to be
testosterone deficient then utilization of injectable
Depo-testosterones 200 mg every two to three weeks
or Androderm testosterone patches 5 mg nightly
should be utilized. Testosterone replacement will
improve sexual desire in men who are testosterone
deficient, but will improve their sexual function
only 50 percent of the time since there are other
factors involved in many of these men including
vascular disease, diabetes, etc.
B. Intraurethral Drugs
Intraurethral
pellets (Muse) was the second medication approved
by the Food and Drug Administration for the treatment
of male erectile dysfunction. It is effective
in approximately 40 percent of males with erectile
dysfunction. It is best used in those patients
with mild to moderate symptoms. Its major side
effect is irritation of the urethra and penile
discomfort which occurs in only 3 percent of patients.
When
used in conjunction with Viagra oral medication
the two drugs are synergistic in their effect
and make for an excellent combination therapy
in those patients in which the Viagra is suboptimal
and/or Muse suboptimal. There have been no studies
on the combination of Viagra and Muse and therefore
the Viagra package insert states that it is not
indicated together. On the other hand, among urologists
who treat impotence, the combination is excellent
and should be tried under physician management.
Muse therapy comes in the dosages of 125, 250,
500, and 1,000 mcg.
A
small toothpick-like applicator holds the 3 mm
pellet which is placed into the urethra quite
easily and painlessly. Massage of the penis within
five to ten minutes causes its erectile effect.
90 percent of the drug is hydrolyzed in the urethra,
and only approximately 10 percent get absorbed
into the spongy rods of the penis as prostaglandin.
C. Injectable Vasoactive Drugs
The
vasoactive drugs that are available for injection
therapy include Prostaglandin E-1 (Caverject,
Edex), papaverine and Regitine, Trimix (papaverine,
Regitine plus Prostaglandin E1), and vasoactive
intestinal polypeptides (VIP). See http://www.planetrx.com/default.html
for more information. Caverject, manufactured
by the UpJohn Company, was the first drug to be
FDA approved for the treatment of impotence.
The
drug is injected directly into the two spongy
rods that make up the penis at its base where
sensation is minimal using a small-gauged needle
and injecting approximately 5 to 20 micrograms
of prostaglandin per dose. The drug is only injected
prior to sexual activity, taking about five to
ten minutes to be active, and lasting anywhere
from one to two hours. It is extremely effective
and works in more than 95 percent of patients.
Contrary
to what most people think, the base of the penis
has minimal pain fibers and injection into the
base of the penis at the two or ten o'clock position
causes minimal to no discomfort. For those men
who are unable to place a needle directly into
the body an autoinjector is available. The major
complications of intracavernosal Prostaglandin
includes penile discomfort in 3 percent of cases,
most rare priapism, and even rarer using good
technique would be injury to the urethra.
Prior
to the widespread use of Prostaglandin, combinations
of papaverine and Regitine were utilized in the
United States. In circumstances in which there
is penile pain with injectable Prostaglandin,
papaverine and Regitine are still utilized. On
some occasions papaverine and Regitine works better
than Prostaglandin and vice versa. The major problems
with papaverine and Regitine are its effect on
the liver it cannot be used in patients with chronic
liver disease, and an erection that will not disappear,
i.e., priapism.
On
rare occasions when Prostaglandin alone or papaverine
and Regitine are not effective, the three are
combined into what is called Trimix and may be
injected in an effective manner.
Vasoactive
intestinal polypeptides (VIP) have been researched
in the Scandinavian countries for injection in
the treatment of impotence. This drug has not
been approved in the United States, it is expensive
and not easily available, and it also causes penile
discomfort.
D. External Vacuum Compression Devices
External
vacuum compression devices are effective in approximately
75 percent of patients. However, the learning
curve is significant, it takes a great deal of
perseverance to learn and utilize, but when mastered
can be used quickly and effectively. It involves
placing a plastic cylinder over the shaft of the
penis, pressing against the base of the pelvis
and pumping some type of a vacuum device which
produces a vacuum in the cylinder sucking blood
into the penis and allowing an erection to form.
As
the vacuum is released and the cylinder is removed,
a compressor band is slipped over the base of
the penis holding the blood within the penis.
Many people find this cosmetically unpleasant
and therefore would not utilize. There have been
no significant serious problems related to a vacuum
compression device if used properly, and if the
constriction band is not allowed to remain in
place more than thirty minutes.
The
device is contraindicated in those patients who
have sickle cell disease or significant anticoagulant
therapy, or have some type of blood dyscrasia
and bleeding problem. There are approximately
15 to 20 manufacturers of these devices with costs
ranging between $89 and $400. Most of the vacuum-producing
components are mechanical; however, there are
battery operated devices as well.
E. Implantable Penile Prosthetic Devices
Penile
prostheses are implanted in those patients in
whom all other therapies are ineffective or suboptimal
or in which the patient is not willing to utilize
other treatment modalities. In general, penile
prostheses are the final way to resolve an impotence
situation. It works, and patient satisfaction
is greater than 99 percent. Partner satisfaction
is approximately 98 percent. The negative press
given to penile prostheses is unwarranted and
for appropriate patients is an excellent way of
resolving their erectile dysfunction.
The
different penile prostheses include semi-rigid
malleable devices, self-contained inflatable devices,
and multi component inflatable devices. In most
cases the multi-component inflatable device should
be utilized since it has the best quality erectile
function with the best cosmetic flaccid situation.
The self-contained prostheses should probably
be used in those males who cannot have a reservoir
within the retroperitoneum due to extensive previous
surgery, but these devices do not have the flaccid
and tumescent properties of the multi-component
variety. Semi-rigid devices; however, can be utilized
in those men who are incapable of utilizing their
hands and do not have partners to manipulate their
inflatable devices.
The
inflatable penile prostheses are manufactured
by two companies; American Medical Systems in
Minnetonka, Minnesota and Mentor Corporation in
Santa Barbara, California. The 10 year success
rate is in the range of 95-97 percent. Major complications
include infection and device malfunction. Infection
occurs in less than 0.5 percent of the nondiabetic
population, and 1.5 percent of the diabetic population.
Obviously, surgery is necessary for all penile
implants taking anywhere from 40 minutes to an
hour and a half to actually do the implantation
under general or spinal anesthesia as a morning
admission with a 23 hour stay or in and out. Revisions
are almost always an in and out procedure.
Patients
are placed on prophylactic antibiotics just prior
to, at the time of, and after their surgery. Significant
discomfort lasts less than two weeks and most
of the devices are functional within four to six
weeks, at which time pain and swelling has disappeared.
F. Future Treatment Modalities
Obviously, an oral drug that will effectively
and safely treat erectile dysfunction is the most
desired. Viagra appears to meet this description,
but does have some minor side effects and cannot
be utilized with nitrates. A long-acting, slow-release
Viagra drug, as well as a rapid release tablet
is being studied at this time. In addition, other
oral medications that don't work through phosphodiesterase
or cyclic GMP system are being tried as well.
Creams including nitroglycerin and prostaglandin
are also in investigational trials. The use of
genetic therapy in which nitric oxide-producing
enzymes are genetically infected through virus
transfer have been experimented in animal studies.
Original
Link
|